Acutus medical completes first closing of transaction with medtronic and debt refinancing to fund strategic growth priorities

Carlsbad, calif., july 01, 2022 (globe newswire) -- acutus medical, inc. (“acutus” or the “company”) (nasdaq: afib), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the completion of the first of two closings for its previously disclosed sale of the company's left-heart access portfolio to medtronic, inc. (“medtronic”) and entry into a new longer-term credit facility with deerfield management company (“deerfield”) to refinance its existing debt. the company expects these transactions to fund its long-term growth objectives.
AFIB Ratings Summary
AFIB Quant Ranking